Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Serosurveillance for vaccine-preventable diseases: A look inside the pertussis experience

Hincapié D, Acevedo M, Hoyos MC, Ochoa J, González C, Pérez PA, Molina A, Restrepo BI, Arrubla M, Echeverri AP, Almanza RE, González LD, Santacruz-Sanmartín E, Orrego NE, Arango D, Gutiérrez AM, Londoño OL, Toro LM, Ríos M, Villada O, Mejía LA, Arenas PA, García D, Osorio E.

Biomedica. 2019 Aug 1;39(Supl. 2):130-143. doi: 10.7705/biomedica.v39i4.4181. English, Spanish.

2.

The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.

Cadena J, Rathinavelu S, Lopez-Alvarenga JC, Restrepo BI.

Tuberculosis (Edinb). 2019 May;116S:S89-S97. doi: 10.1016/j.tube.2019.04.015. Epub 2019 May 3.

PMID:
31085129
3.

Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.

Rashak HA, Sánchez-Pérez HJ, Abdelbary BE, Bencomo-Alerm A, Enriquez-Ríos N, Gómez-Velasco A, Colorado A, Castellanos-Joya M, Rahbar MH, Restrepo BI.

Epidemiol Infect. 2019 Jan;147:e71. doi: 10.1017/S0950268818003461.

4.

Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Restrepo BI, Kleynhans L, Salinas AB, Abdelbary B, Tshivhula H, Aguillón-Durán GP, Kunsevi-Kilola C, Salinas G, Stanley K, Malherbe ST, Maasdorp E, Garcia-Viveros M, Louw I, Garcia-Oropesa EM, Lopez-Alvarenga JC, Prins JB, Walzl G, Schlesinger LS, Ronacher K.

Tuberculosis (Edinb). 2018 Dec;113:10-18. doi: 10.1016/j.tube.2018.08.007. Epub 2018 Aug 18.

5.

Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen.

Choudhary A, Patel D, Honnen W, Lai Z, Prattipati RS, Zheng RB, Hsueh YC, Gennaro ML, Lardizabal A, Restrepo BI, Garcia-Viveros M, Joe M, Bai Y, Shen K, Sahloul K, Spencer JS, Chatterjee D, Broger T, Lowary TL, Pinter A.

J Immunol. 2018 May 1;200(9):3053-3066. doi: 10.4049/jimmunol.1701673. Epub 2018 Apr 2.

6.

Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico.

Abdelbary BE, Garcia-Viveros M, Ramirez-Oropesa H, Rahbar MH, Restrepo BI.

Epidemiol Infect. 2017 Oct;145(14):3020-3034. doi: 10.1017/S0950268817001911. Epub 2017 Sep 14.

PMID:
28903800
7.

Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Ronacher K, van Crevel R, Critchley JA, Bremer AA, Schlesinger LS, Kapur A, Basaraba R, Kornfeld H, Restrepo BI.

Chest. 2017 Jul;152(1):174-180. doi: 10.1016/j.chest.2017.02.032. Epub 2017 Apr 20. Review.

8.

Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.

Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS, Basaraba R, Kornfeld H, van Crevel R.

Chest. 2017 Jul;152(1):165-173. doi: 10.1016/j.chest.2017.04.155. Epub 2017 Apr 20. Review.

9.

The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes.

Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, Duggirala R, Morales-Romero J, López-Alvarenga JC, Comas I, Zenteno-Cuevas R.

Tuberculosis (Edinb). 2017 Mar;103:83-91. doi: 10.1016/j.tube.2017.01.006. Epub 2017 Jan 24.

PMID:
28237037
10.

Diabetes and Tuberculosis.

Restrepo BI.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.TNMI7-0023-2016. Review.

11.

Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico.

Abdelbary BE, Garcia-Viveros M, Ramirez-Oropesa H, Rahbar MH, Restrepo BI.

Tuberculosis (Edinb). 2016 Dec;101S:S124-S134. doi: 10.1016/j.tube.2016.09.024. Epub 2016 Sep 28.

PMID:
27733244
12.

Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.

Agarwal S, Nguyen DT, Lew JD, Teeter LD, Yamal JM, Restrepo BI, Brown EL, Dorman SE, Graviss EA.

Tuberculosis (Edinb). 2016 Dec;101S:S83-S91. doi: 10.1016/j.tube.2016.09.012. Epub 2016 Sep 28.

PMID:
27727133
13.

Comparing TSPOT assay results between an Elispot reader and manual counts.

Agarwal S, Nguyen DT, Lew JD, Teeter LD, Yamal JM, Restrepo BI, Brown EL, Dorman SE, Graviss EA.

Tuberculosis (Edinb). 2016 Dec;101S:S92-S98. doi: 10.1016/j.tube.2016.09.013. Epub 2016 Sep 28.

PMID:
27727132
14.

Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.

Restrepo BI.

Tuberculosis (Edinb). 2016 Dec;101S:S69-S72. doi: 10.1016/j.tube.2016.09.008. Epub 2016 Sep 28. Review.

PMID:
27720378
15.

A Functional Role for Antibodies in Tuberculosis.

Lu LL, Chung AW, Rosebrock TR, Ghebremichael M, Yu WH, Grace PS, Schoen MK, Tafesse F, Martin C, Leung V, Mahan AE, Sips M, Kumar MP, Tedesco J, Robinson H, Tkachenko E, Draghi M, Freedberg KJ, Streeck H, Suscovich TJ, Lauffenburger DA, Restrepo BI, Day C, Fortune SM, Alter G.

Cell. 2016 Oct 6;167(2):433-443.e14. doi: 10.1016/j.cell.2016.08.072. Epub 2016 Sep 22.

16.

Impact of diabetes on the natural history of tuberculosis.

Restrepo BI, Schlesinger LS.

Diabetes Res Clin Pract. 2014 Nov;106(2):191-9. doi: 10.1016/j.diabres.2014.06.011. Epub 2014 Jul 14. Review.

17.

A missed tuberculosis diagnosis resulting in hospital transmission.

Medrano BA, Salinas G, Sanchez C, Miramontes R, Restrepo BI, Haddad MB, Lambert LA.

Infect Control Hosp Epidemiol. 2014 May;35(5):534-7. doi: 10.1086/675833. Epub 2014 Mar 14.

18.

Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia.

Restrepo BI, Twahirwa M, Rahbar MH, Schlesinger LS.

PLoS One. 2014 Mar 26;9(3):e92977. doi: 10.1371/journal.pone.0092977. eCollection 2014.

19.

Epidemiology of tuberculosis in young children in the United States.

Pang J, Teeter LD, Katz DJ, Davidow AL, Miranda W, Wall K, Ghosh S, Stein-Hart T, Restrepo BI, Reves R, Graviss EA; Tuberculosis Epidemiologic Studies Consortium.

Pediatrics. 2014 Mar;133(3):e494-504. doi: 10.1542/peds.2013-2570. Epub 2014 Feb 10.

20.

Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity.

Stew SS, Martinez PJ, Schlesinger LS, Restrepo BI.

Tuberculosis (Edinb). 2013 Dec;93 Suppl:S78-82. doi: 10.1016/S1472-9792(13)70015-5.

21.

Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus.

Restrepo BI, Schlesinger LS.

Tuberculosis (Edinb). 2013 Dec;93 Suppl:S10-4. doi: 10.1016/S1472-9792(13)70004-0. Review.

22.

Dipstick urinalysis for diabetes screening in TB patients.

Restrepo BI, Pino PA, Zarate I, Mora-Guzman F.

Int Health. 2013 Jun;5(2):157-9. doi: 10.1093/inthealth/iht007.

23.

Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis.

Pollock NR, Macovei L, Kanunfre K, Dhiman R, Restrepo BI, Zarate I, Pino PA, Mora-Guzman F, Fujiwara RT, Michel G, Kashino SS, Campos-Neto A.

J Clin Microbiol. 2013 May;51(5):1367-73. doi: 10.1128/JCM.03192-12. Epub 2013 Feb 6.

24.

Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control.

Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI.

Tuberculosis (Edinb). 2013 Mar;93(2):192-7. doi: 10.1016/j.tube.2012.10.003. Epub 2012 Nov 3. Erratum in: Tuberculosis (Edinb). 2014 Sep;94(5):533.

25.

Validation of increased blood storage times with the T-SPOT.TB assay with T-Cell Xtend reagent in individuals with different tuberculosis risk factors.

Wang SH, Stew SS, Cyktor J, Carruthers B, Turner J, Restrepo BI.

J Clin Microbiol. 2012 Jul;50(7):2469-71. doi: 10.1128/JCM.00674-12. Epub 2012 Apr 18.

26.

Rapid DNA extraction for specific detection and quantitation of Mycobacterium tuberculosis DNA in sputum specimens using Taqman assays.

Gomez DI, Mullin CS, Mora-Guzmán F, Crespo-Solis JG, Fisher-Hoch SP, McCormick JB, Restrepo BI.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S43-8. doi: 10.1016/j.tube.2011.10.009. Epub 2011 Nov 15.

27.

Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases.

Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Zarate I, Mora-Guzmán F, Crespo-Solis JG, Briggs J, McCormick JB, Fisher-Hoch SP.

Bull World Health Organ. 2011 May 1;89(5):352-9. doi: 10.2471/BLT.10.085738. Epub 2011 Mar 30.

28.

The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes.

Walsh MC, Camerlin AJ, Miles R, Pino P, Martinez P, Mora-Guzmán F, Crespo-Solis JG, Fisher-Hoch SP, McCormick JB, Restrepo BI.

Int J Tuberc Lung Dis. 2011 Feb;15(2):179-84, i-iii.

29.

Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007.

Fisher-Hoch SP, Rentfro AR, Salinas JJ, Pérez A, Brown HS, Reininger BM, Restrepo BI, Wilson JG, Hossain MM, Rahbar MH, Hanis CM, McCormick JB.

Prev Chronic Dis. 2010 May;7(3):A53. Epub 2010 Apr 15.

30.

Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria.

Gomez DI, Fisher-Hoch SP, Bordt AS, Quitugua TN, Robledo J, Alvarez N, Correa N, McCormick JB, Restrepo BI.

Diagn Microbiol Infect Dis. 2010 May;67(1):37-46. doi: 10.1016/j.diagmicrobio.2009.12.007. Epub 2010 Mar 12.

31.

Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Restrepo BI, Fisher-Hoch SP, Smith B, Jeon S, Rahbar MH, McCormick JB; Nuevo Santander Tuberculosis Trackers.

Am J Trop Med Hyg. 2008 Oct;79(4):541-4.

32.

Type 2 diabetes and multidrug-resistant tuberculosis.

Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, Restrepo BI.

Scand J Infect Dis. 2008;40(11-12):888-93. doi: 10.1080/00365540802342372.

33.

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, Cortes-Penfield N, McCormick JB.

Clin Infect Dis. 2008 Sep 1;47(5):634-41. doi: 10.1086/590565.

34.

Interpretation of mycobacterial antibodies in the cerebrospinal fluid of adults with tuberculous meningitis.

Restrepo BI, Pino PA, Volcy M, Franco AF, Kanaujia GV, Robledo J.

Trop Med Int Health. 2008 May;13(5):653-8. doi: 10.1111/j.1365-3156.2008.02053.x.

35.

Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances.

Restrepo BI.

Clin Infect Dis. 2007 Aug 15;45(4):436-8. Epub 2007 Jul 5. No abstract available.

36.

Pathogen escape from host immunity by a genome program for antigenic variation.

Barbour AG, Dai Q, Restrepo BI, Stoenner HG, Frank SA.

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18290-5. Epub 2006 Nov 13.

37.

Type 2 diabetes and tuberculosis in a dynamic bi-national border population.

Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, McCormick JB; Nuevo Santander Tuberculosis Trackers.

Epidemiol Infect. 2007 Apr;135(3):483-91. Epub 2006 Jul 25.

38.

Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids.

Dai Q, Restrepo BI, Porcella SF, Raffel SJ, Schwan TG, Barbour AG.

Mol Microbiol. 2006 Jun;60(6):1329-43. Erratum in: Mol Microbiol. 2006 Aug;61(3):838.

39.

Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens.

Restrepo BI, Gomez DI, Shipley GL, McCormick JB, Fisher-Hoch SP.

J Microbiol Methods. 2006 Nov;67(2):220-9. Epub 2006 May 5.

40.

Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas.

Pérez A, Brown HS 3rd, Restrepo BI.

Am J Trop Med Hyg. 2006 Apr;74(4):604-11.

41.

[New tools for detection of latent tuberculosis].

Restrepo BI.

Biomedica. 2004 Jun;24 Supp 1:202-11. Review. Spanish.

PMID:
15495587
42.

Diagnosis of tuberculosis lymphadenitis using a polymerase chain reaction on peripheral blood mononuclear cells.

Mirza S, Restrepo BI, McCormick JB, Fisher-Hoch SP.

Am J Trop Med Hyg. 2003 Nov;69(5):461-5.

PMID:
14695080
43.

In situ detection of antigenic glycoproteins in Taenia solium metacestodes.

Obregón-Henao A, Londoño DP, Gómez DI, Trujillo J, Teale JM, Restrepo BI.

J Parasitol. 2003 Aug;89(4):726-32.

PMID:
14533682
44.

Similar diagnostic performance for neurocysticercosis of three glycoprotein preparations from Taenia solium metacestodes.

Villota GE, Gomez DI, Volcy M, Franco AF, Cardona EA, Isaza R, Sanzón F, Teale JM, Restrepo BI.

Am J Trop Med Hyg. 2003 Mar;68(3):276-80.

PMID:
12685629
45.

Structural characterization of the N-linked glycans from Taenia solium metacestodes.

Haslam SM, Restrepo BI, Obregón-Henao A, Teale JM, Morris HR, Dell A.

Mol Biochem Parasitol. 2003 Jan;126(1):103-7. No abstract available.

PMID:
12554090
46.

The inflammatory cell infiltrates in porcine cysticercosis: immunohistochemical analysis during various stages of infection.

Londoño DP, Alvarez JI, Trujillo J, Jaramillo MM, Restrepo BI.

Vet Parasitol. 2002 Nov 11;109(3-4):249-59.

PMID:
12423936
47.

Granuloma formation and parasite disintegration in porcine cysticercosis: comparison with human neurocysticercosis.

Alvarez JI, Londoño DP, Alvarez AL, Trujillo J, Jaramillo MM, Restrepo BI.

J Comp Pathol. 2002 Aug-Oct;127(2-3):186-93.

PMID:
12354530
48.

The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response.

Alvarez JI, Colegial CH, Castaño CA, Trujillo J, Teale JM, Restrepo BI.

J Neuroimmunol. 2002 Jun;127(1-2):139-44.

PMID:
12044985
49.

Serological screening for cysticercosis in mentally altered individuals.

Sanzón F, Osorio AM, Morales JP, Isaza R, Cardona E, Moncayo LC, Villota GE, Zapata OT, Palacio CA, Arbeláez MP, Restrepo BI.

Trop Med Int Health. 2002 Jun;7(6):532-8.

50.

Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.

Melby PC, Tabares A, Restrepo BI, Cardona AE, McGuff HS, Teale JM.

Exp Parasitol. 2001 Sep;99(1):17-25.

PMID:
11708830

Supplemental Content

Loading ...
Support Center